FY2025 · ended Dec 31, 2025 · Revenue $24.25M, +30.5% YoY · Filed Mar 30, 2026
Precipio, Inc. (PRPO) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $24.2 million and a net loss of $363,000. Free cash flow was $359,000. As of Jun 30, 2026 it held $3.1 million in cash and investments and $3.6 million in total debt.
Revenue (TTM)
$27.69M
+31.0% vs year-ago TTM
Net income
$-363,000
+97.3% vs prior year
Operating cash flow (TTM)
$1.10M
+20.2% vs year-ago TTM
Free cash flow (TTM)
$789,000
+39.6% vs year-ago TTM
EPS
$-0.23
+92.2% vs prior year
Dividend per share
None
Shares outstanding
1.78M
+18.6% vs prior year
Net cash
$-513,000
as of Jun 30, 2026
Operating margin
-5.6%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- PRPO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1043961
- Former names
- TRANSGENOMIC INC (until Jun 30, 2017)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $24.2M | $18.6M | $15.4M | $9.8M | $8.7M |
| Operating income | -$1.2M | -$4.2M | -$7.6M | -$12.8M | -$9.6M |
| Net income | -$363,000 | — | — | — | — |
| Diluted EPS | -$0.23 | -$2.93 | -$4.51 | -$10.73 | -$0.40 |
| Operating cash flow | $685,000 | $439,000 | -$3.6M | -$7.7M | -$6.6M |
| Free cash flow | $359,000 | $216,000 | -$3.7M | -$8.0M | -$7.3M |
| Total assets | $21.3M | $17.0M | $18.1M | $21.5M | $30.4M |
| Total liabilities | $6.8M | $4.9M | $3.7M | $5.1M | $5.8M |
| Stockholders' equity | $14.6M | $12.1M | $14.4M | $16.4M | $24.6M |
| Cash and investments | $2.7M | $1.4M | $1.5M | $3.4M | $11.7M |
| Total debt | $3.7M | $1.3M | $1.1M | $1.4M | $1.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
All 1000 Precipio, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.